GPT and steatosis: Preclinical: consistently shows attenuation of steatosis, lobular inflammation, hepatocyte ballooning, and fibrosis in animal models of NASHSignificantly reduces serum transaminases (ALT and AST) and hepatic markers of oxidative stress